Agreement facilitates flexible, scalable automated industrialized production of rese-cel for many thousands of patients per year at a cost per batch that is among the lowest in the industry ...

(R to L) EY's Ricardo Vilanova, Lila Bioscience's Molly Gibson, Merck's Iya Khalil, Insitro's Mary Rozenman, and Gallop Oncology's Luba Greenwood at BIO 2025. When Google shook the foundations of the ...

BOCA RATON, Fla., April 16, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage biotechnology company focused on developing therapies that harness the patient’s ...

Shares of Cogent Biosciences (COGT) climbed ~120% in the premarket on Monday after the company disclosed encouraging late-stage trial data for its lead asset, bezuclastinib, against a form of ...

Brand new UK startup RQ Biotechnology has been thrust into the spotlight after signing a $157 million licensing deal with AstraZeneca for monoclonal antibodies intended to protect vulnerable and ...

Regeneron rebounds from regulatory and clinical setbacks as Dupixent and pipeline catalysts fuel growth. Click here to read ...

BioWorld tracked 209 clinical trial readouts across phases I through III in March 2026, up from 152 in February and 144 in January. Among late-stage programs, 26 phase III trials reported positive ...

George Halas McCaskey became the fourth Chairman in Chicago Bears team history on May 5, 2011, following in the footsteps of his grandfather, George Halas, father, Edward W. McCaskey and brother, ...

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life ...

Access detailed historical stock prices, including daily closing prices, for NUVB. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...

China is accelerating its AI ambitions as Alibaba launches a 10,000-card computing cluster powered by domestic chips, signalling a strategic push to rival US tech giants through large-scale ...

Apr. 7, 2026 A gene called KLF5 may be a key force behind the spread of pancreatic cancer—but not in the way scientists expected. Rather than mutating DNA, it rewires how genes are turned on and off, ...